Axsome Thera (AXSM)
$71.17
1.91 (2.61%)
AXSM Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's a new week and that means it's time for us to start it off with a look at the biggest pre-market stock movers for Monday!
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
3.36B
PE Ratio
-16.55
EPS
-4.3
Volume (Avg. Vol.)
583,518
Day's Range
$69.92 - $73.14
52-Week Range
$55.02 - $98.40
Dividend & Yield
N/A (N/A)
AXSM Stock Predictions, Articles, and Axsome Thera News
Axsome Therapeutics News: AXSM Stock Rockets 76% on Depressive Disorder Drug Results
Axsome Therapeutics (AXSM) news for Monday about results from the company's Phase 3 Trial of AXS-05 has AXSM stock rocketing higher.
Axsome Therapeutics: Do Not Buy AXSM Stock After Its Monster Rally
No longer a penny stock, Axsome Therapeutics (AXSM) surged past $8 a share on news that its AXS-05 treatment affected a 17.2-point drop in patients on the Montgomery-Asbert Depression Rating Scale. But is it a buy?
AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing Today
Axsome Therapeutics (AXSM) stock was flying high on Monday following some good AXSM news about a recent Phase 2 drug trial.
